Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENHANCE
NCT03845751Phase 2Completed
- Sponsor
- Institut Mutualiste Montsouris
- Start
- Mar 2023
- Primary completion
- Jul 2026
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of leuprolide in prostate cancer (PCa), sponsored by Institut Mutualiste Montsouris. Started Mar 2023; status: completed.
02
Drugs
leuprolide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03845751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03845751.